Marinus Pharmaceuticals financials at a glance
| Year | Year | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $1.72M | $15.35M | $25.48M | $30.99M | $0.00M |
| GM % | Gross Margin % |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -219.57% | -226.96% | 0.00% |
| OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | Earnings Per Share |
|
$-8.68 | $-6.68 | $-5.88 | $-3.20 | $-3.60 | $-3.96 | $-2.80 | $-2.65 | $-3.26 | $-2.70 | $0.00 |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sha. | Shares |
|
3.5m | 4.83m | 4.93m | 10.11m | 13.13m | 20.57m | 35.59m | 36.77m | 37.02m | 54.57m | 54.57m |
| OCF | Operating Cash Flow |
|
$-8.59M | $-20.13M | $-24.77M | $-18.82M | $-27.84M | $-48.63M | $-60.91M | $-55.48M | $-112.89M | $-118.00M | $0.00M |
| FCF | Free Cash Flow |
|
$-8.62M | $-27.83M | $-25.41M | $-19.27M | $-27.92M | $-49.02M | $-60.91M | $-56.57M | $-114.66M | $-67.00M | $0.00M |
| FCFS | Free Cash Flow Per Share |
|
$-5.61 | $-5.49 | $-5.21 | $-3.27 | $-2.73 | $-3.60 | $-2.23 | $-1.59 | $-2.93 | $-2.20 | $0.00 |